Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (2): 51-59.doi: 10.6040/j.issn.1671-7554.0.2023.1092

• Clinical Medicine • Previous Articles     Next Articles

Establishment and value assessment of colon cancer diagnostic models based on multiple variables and different machine learning algorithms

LIANG Yongyuan1, CAI Peifei2, ZHENG Guixi1   

  1. 1. Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Blood Transfusion, Affiliated Hospital of Jining Medical College, Jining 272000, Shandong, China
  • Published:2024-03-29

PDF (PC)

599

Abstract: Objective To establish a colon cancer diagnostic model based on multiple variables using various machine learning algorithms and to assess its clinical application value. Methods Serum samples from 119 colon cancer patients and 125 healthy controls were collected. Serum exosome was extracted, and miRNA 214-3p(miR-214-3p)level was measured using RT-qPCR. Receiver operating characteristic(ROC)curve was plotted to evaluate the diagnostic efficiency of colon cancer. Additionally, 30 routine laboratory items of colon cancer patients and healthy controls were collected. Characteristic variables were screened, and 11 algorithms were used to establish the diagnostic model. The optimal model was selected with ROC and machine learning curves. Results The expression level of miR-214-3p in colon cancer patients was significantly higher than that in healthy controls(P<0.001), with the area under the ROC curve(AUC)being 0.820, indicating good diagnostic performance. After the expression level of miR-214-3p and other 30 routine laboratory items were enrolled, 4 characteristic variables were screened to establish the diagnostic model, including UREA, carcinoembryonic antigen, monocyte and miR-214-3p. The Logistic regression algorithm was identified as the optimal one(AUC=0.93). Conclusion Serum exosome miR-214-3p is a potential biomarker of colon cancer. The model based on 4 characteristic variables and Logistic regression algorithm has an excellent diagnostic performance for diagnosing colon cancer.

Key words: Colon cancer, miR-214-3p, Exosome, Machine learning

CLC Number: 

  • R783
[1] 闫超, 陕飞, 李子禹. 2020年中国与全球结直肠癌流行概况分析[J]. 中华肿瘤杂志, 2023, 45(3): 221-229. YAN Chao, SHAN Fei, LI Ziyu. Epidemiological analysis of colorectal cancer in China and the world in 2020. Chinese Journal of Cancer, 2019, 45(3): 221-229.
[2] Fabregas JC, Ramnaraign B, George TJ. Clinical updates for colon cancer care in 2022[J]. Clin Colorectal Cancer, 2022, 21(3): 198-203.
[3] Su Y, Tian X, Gao R, et al. Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis[J]. Comput Biol Med, 2022, 145: 105409. doi: 10.1016/j.compbiomed.2022.105409.
[4] Tang S, Cheng J, Yao Y, et al. Combination of four serum exosomal miRNAs as novel diagnostic biomarkers for early-stage gastric cancer[J]. Front Genet, 2020, 11: 237. doi:10.3389/fgene.2020.00237.
[5] Miao C, Zhang W, Feng L, et al. Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia[J]. Mol Ther Nucleic Acids, 2021, 24: 923-938. doi: 10.1016/j.omtn.2021.04.015.
[6] Wei W, Li Y, Huang T. Using machine learning methods to study colorectal cancer tumor micro-environment and its biomarkers[J]. Int J Mol Sci, 2023, 24(13): 11133. doi: 10.3390/ijms241311133.
[7] Nguyen QTN, Nguyen PA, Wang CJ, et al. Machine learning approaches for predicting 5-year breast cancer survival: a multicenter study[J]. Cancer Sci, 2023, 114(10): 4063-4072.
[8] Lannagan TR, Jackstadt R, Leedham SJ, et al. Advances in colon cancer research: in vitro and animal models[J]. Curr Opin Genet Dev, 2021, 66: 50-56. doi: 10.1016/j.gde.2020.12.003.
[9] Ahmed M. Colon cancer: a clinicians perspective in 2019[J]. Gastroenterology Res, 2020, 13(1): 1-10.
[10] Khan SZ, Lengyel CG. Challenges in the management of colorectal cancer in low- and middle-income countries[J]. Cancer Treat Res Commun, 2023, 35: 100705. doi: 10.1016/j.ctarc.2023.100705.
[11] Verkuijl SJ, Jonker JE, Trzpis M, et al. Functional outcomes of surgery for colon cancer: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2021, 47(5): 960-969.
[12] 刘睿清, 卢云. 基于循证医学的早期结肠癌外科治疗进展[J]. 中华胃肠外科杂志,2022, 25(12): 1144-1149. LIU Ruiqing, LU Yun. Advances in surgical treatment of early colon cancer based on evidence-based medicine[J]. Chinese Journal of Gastrointestinal Surgery, 2002, 25(12): 1144-1149.
[13] Chan SCH, Liang JQ. Advances in tests for colorectal cancer screening and diagnosis[J]. Expert Rev Mol Diagn, 2022, 22(4): 449-460.
[14] Birgisson H, Olafsdottir EJ, Sverrisdottir A, et al. Screening for cancer of the colon and rectum a review on incidence, mortality, cost and benefit[J]. Laeknabladid, 2021, 107(9): 398-405.
[15] Jain S, Maque J, Galoosian A, et al. Optimal strategies for colorectal cancer screening[J]. Curr Treat Options Oncol, 2022, 23(4): 474-493.
[16] Shaukat A, Levin TR. Current and future colorectal cancer screening strategies[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(8): 521-531.
[17] Liang G, Zhu Y, Ali DJ, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J]. J Nanobiotechnology, 2020, 18(1): 10. doi: 10.1186/s12951-019-0563-2.
[18] Wang L, Song X, Yu M, et al. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer[J]. Future Oncol, 2022, 18(7): 793-805.
[19] Maeda K, Sasaki H, Ueda S, et al. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer[J]. J Ovarian Res, 2020, 13(1): 47. doi: 10.1186/s13048-020-00648-1.
[20] Karimi E, Dehghani A, Azari H, et al. Molecular mechanisms of miR-214 involved in cancer and drug resistance[J]. Curr Mol Med, 2023, 23(7): 589-605.
[21] He GN, Bao NR, Wang S, et al. Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4[J]. Drug Des Devel Ther, 2021, 15: 3965-3978. doi: 10.2147/dddt.S332847.
[22] Wu Y, Xu X. Long non-coding RNA signature in colorectal cancer: research progression and clinical application[J]. Cancer Cell Int, 2023, 23(1): 28. doi: 10.1186/s12935-023-02867-0.
[23] Sukmana BI, Al-Hawary SIS, Abosaooda M, et al. A thorough and current study of miR-214-related targets in cancer[J]. Pathol Res Pract, 2023, 249:154770. doi: 10.1016/j.prp.2023.154770.
[24] Hossain MS, Karuniawati H, Jairoun AA, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies[J]. Cancers(Basel), 2022, 14(7): 1732. doi: 10.3390/cancers14071732.
[25] Wang C, Sun H, Liu J. BUN level is associated with cancer prevalence[J]. Eur J Med Res, 2023, 28(1): 213. doi: 10.1186/s40001-023-01186-4.
[26] Qin WH, Yang ZS, Li M, et al. High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice[J]. Gastroenterology, 2020, 158(6): 1713-1727.
[27] Larionova I, Patysheva M, Iamshchikov P, et al. PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse[J]. Front Immunol, 2022, 13: 1080501. doi: 10.3389/fimmu.2022.1080501.
[28] Yu K, Qiang G, Peng S, et al. Potential diagnostic value of the hematological parameters lymphocyte-monocyte ratio and hemoglobin-platelet ratio for detecting colon cancer[J]. J Int Med Res, 2022, 50(9): 3000605221122742. doi: 10.1177/03000605221122742.
[1] LIAO Yuan, MEN Dan, LI Yifan, LI Huaichen, LONG Fei, LIU Yi. Short-term effect of PM2.5 on the incidence of tuberculosis based on individual precise exposure assessment [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 116-123.
[2] LIU Yu, HUO Yaya, GONG Cheng, LIANG Ting, LI Bin. Design and optimization of orthopedic biomaterials based on machine learning [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 22-33.
[3] WANG Jianmin, LI Xiaofeng, YOU Zhitao, DONG Shengjie, ZHAO Yuchi, LI Zhanju, ZOU Dexin, ZHANG Jianfeng, SUN Tao, DU Wei. Construction of a chronic post-surgical pain prediction model for posterior lumbar interbody fusion surgery based on interpretable machine learning [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 78-88.
[4] WANG Liyun, GAO Tianqin, LIU Yujia, CHEN Qing, CHEN Liu, SHA Kaihui. Development and validation of a postpartum stress urinary incontinence risk prediction model based on machine learning [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 55-66.
[5] WANG Jing, LIU Xiaofei, ZENG Rong, XU Changjuan, ZHANG Jintao, DONG Liang. Identification of necroptosis-related biomarkers in asthma based on machine learning algorithms [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 21-32.
[6] GUO Zhenjiang, WANG Ning, ZHAO Guangyuan, DU Liqiang, CUI Zhaobo, LIU Fangzhen. Development of preoperative models for predicting positive esophageal margin in proximal gastric cancer based on machine learning [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 78-83.
[7] FENG Xumei, SONG Xiangqing, JI Guanhong, ZHAO Xiaogang, XIAO Zhaohua. Expression and diagnostic value of plasma exosomal miR-548k in esophageal squamous cell carcinoma [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 79-88.
[8] LIU Aijing, LI Yanru, GAO Huiru, DUAN Weili, LI Peilong, LI Juan, DU Lutao, WANG Chuanxin. Expression of autophagy-related protein 5 in colon cancer and its impact on the migration and invasion ability of colon cancer cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 14-23.
[9] WANG Yutao, SUN Yan. Comprehensive analysis of single-cell transcriptomics and machine learning reveals potential biomarkers for abdominal aortic aneurysm [J]. Journal of Shandong University (Health Sciences), 2024, 62(11): 40-53.
[10] ZHANG Jinghui, WANG Juan, ZHAO Yujie, DUAN Miao, LIU Yiran, LIN Minjuan, QIAO Xu, LI Zhen, ZUO Xiuli. Construction of a machine learning-based tongue diagnosis model for gastrointestinal diseases [J]. Journal of Shandong University (Health Sciences), 2024, 62(1): 38-47.
[11] DONG Yaqi, WANG Xinhui, ZHAO Yinghui, WANG Chuanxin. Clinical value of serum exosomal LINC02163 as a marker for distant metastasis of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(9): 19-28.
[12] ZHAO Yuanyuan, LU Juntao, WU Xiaohua. Effects of human umbilical cord mesenchymal stem cell-derived exosomal miR-100 on inflammation of ovarian granulosa cells in polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 51-58.
[13] Yajun LIU,Zhao LANG,Anyi GUO,Wenyong LIU. Progresses and trends of intelligent technologies in orthopedic shock wave therapy [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 7-13.
[14] Nan WU,Jianguo ZHANG,Yuanpeng ZHU,Guilin CHEN,Zefu CHEN. Application of artificial intelligence in the diagnosis and treatment of spinal deformity [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 14-20.
[15] ZHU Zhengyang, SHEN Jingfei, CHEN Sixuan, YE Meiping, YANG Huiquan, ZHOU Jianan, LIANG Xue, ZHANG Xin, ZHANG Bing. Prediction of isocitrate dehydrogenase mutation in glioma with different radiomic models based on susceptibility-weighted imaging [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 44-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd